| Trial Identifier: | D419BR00018 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT04449861 |
| Start Date: | December 2020 |
| Primary Completion Date: | March 2023 |
| Study Completion Date: | March 2023 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Simplified Chinese (China) |
| Country | Location |
|---|---|
| CN | Baoding, CN, 071000 |
| CN | Beijing, CN, 100021 |
| CN | Changchun, CN, 130012 |
| CN | Chengdu, CN, 610041 |
| CN | Dalian, CN, 116001 |
| CN | Dongyang, CN, 322100 |
| CN | Fuzhou, CN, 350009 |
| CN | Guangdong, CN, 510300 |
| CN | Guangdong, CN, 510120 |
| CN | Guangzhou, CN, 510080 |
| CN | Guangzhou, CN, 510120 |
| CN | Guangzhou, CN, 510280 |
| CN | Haerbin, CN, 150081 |
| CN | Hangzhou, CN, 310022 |
| CN | Hangzhou, CN, 310016 |
| CN | Hefei, CN, 230000 |
| CN | Huai'an, CN, 223000 |
| CN | Jiangyin, CN, 214400 |
| CN | Jinan, CN, 250117 |
| CN | Jinhua, CN, 321099 |
| CN | Kunming, CN, 650118 |
| CN | Nanchang, CN, 330000 |
| CN | Nanjing, CN, 210032 |
| CN | Ningbo, CN, 315000 |
| CN | Qingdao, CN, 266100 |
| CN | Shanghai, CN, 200025 |
| CN | Shanghai, CN, 200040 |
| CN | Shanghai, CN, 200032 |
| CN | Shenzhen, CN, 518116 |
| CN | ShenZhen, CN, 518020 |
| CN | Suzhou, CN, 215000 |
| CN | Taiyuan, CN, 030000 |
| CN | Taizhou, CN, 318000 |
| CN | Tianjin, CN, 300060 |
| CN | Whenzhou, CN, 325000 |
| CN | Wuhan, CN, 430022 |
| CN | Wuxi, CN, 214023 |
| CN | Yangzhou, CN, 225012 |
| CN | Zhengzhou, CN, 450000 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company